لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Pecci F; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Nakazawa S; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Ricciuti B; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Harada G; Department of Medical Oncology, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York., Lee JK; Foundation Medicine, Cambridge, Massachusetts., Alessi JV; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Barrichello A; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Vaz VR; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Lamberti G; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Di Federico A; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Gandhi MM; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Gazgalis D; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts., Feng WW; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Jiang J; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Baldacci S; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Locquet MA; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Gottlieb FH; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Chen MF; Department of Medical Oncology, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York., Lee E; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Haradon D; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Smokovich A; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Voligny E; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Nguyen T; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Goel VK; Turning Point Therapeutics, Bristol Myers Squibb Company, San Diego, California., Zimmerman Z; Turning Point Therapeutics, Bristol Myers Squibb Company, San Diego, California., Atwal S; Turning Point Therapeutics, Bristol Myers Squibb Company, San Diego, California., Wang X; Department of Environmental Health, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts., Bahcall M; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Heist RS; Massachusetts General Hospital, Boston, Massachusetts., Iqbal S; The Center for the Development of Therapeutics, Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, Massachusetts., Gandhi N; Caris Life Sciences, Phoenix, Arizona., Elliott A; Caris Life Sciences, Phoenix, Arizona., Vanderwalde AM; Caris Life Sciences, Phoenix, Arizona., Ma PC; Penn State Cancer Institute, Penn State College of Medicine, Penn State University, Hershey, Pennsylvania., Halmos B; Montefiore Einstein Cancer Center, Bronx, New York., Liu SV; Georgetown University, Washington, DC., Che J; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts., Schrock AB; Foundation Medicine, Cambridge, Massachusetts., Drilon A; Department of Medical Oncology, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York., Jänne PA; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Awad MM; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

المصدر: Cancer discovery [Cancer Discov] 2024 Aug 02; Vol. 14 (8), pp. 1440-1456.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE

مواضيع طبية MeSH: Proto-Oncogene Proteins c-met*/genetics , Proto-Oncogene Proteins c-met*/antagonists & inhibitors , Lung Neoplasms*/genetics , Lung Neoplasms*/drug therapy , Lung Neoplasms*/pathology , Protein Kinase Inhibitors*/therapeutic use , Protein Kinase Inhibitors*/pharmacology , Point Mutation*, Humans ; Animals ; Mice ; Cell Line, Tumor

المؤلفون: Morgenstern-Kaplan D; Department of Medicine, Division of Medical Oncology, University of Miami Sylvester Comprehensive Cancer Center/Jackson Memorial Hospital, Miami, FL 33131, United States., Kareff SA; Department of Medicine, Division of Medical Oncology, University of Miami Sylvester Comprehensive Cancer Center/Jackson Memorial Hospital, Miami, FL 33131, United States., Trabolsi A; Department of Medicine, Division of Medical Oncology, University of Miami Sylvester Comprehensive Cancer Center/Jackson Memorial Hospital, Miami, FL 33131, United States., Rodriguez E; Department of Medicine, Division of Medical Oncology, University of Miami Sylvester Comprehensive Cancer Center/Jackson Memorial Hospital, Miami, FL 33131, United States., Krause H; Caris Life Sciences, Phoenix, AZ 85040, United States., Ribeiro JR; Caris Life Sciences, Phoenix, AZ 85040, United States., Tan H; Department of Medicine, Division of Medical Oncology, University of Miami Sylvester Comprehensive Cancer Center/Jackson Memorial Hospital, Miami, FL 33131, United States., Antonarakis ES; University of Minnesota Masonic Cancer Center, Minneapolis, MN 55455, United States., Lou E; University of Minnesota Masonic Cancer Center, Minneapolis, MN 55455, United States., Nagasaka M; Division of Hematology/Oncology, University of California Irvine School of Medicine, Orange, CA 92617, United States., Algaze S; Division of Medical Oncology, Keck School of Medicine of University of Southern California, Los Angeles, CA 90033, United States., Lenz HJ; Division of Medical Oncology, Keck School of Medicine of University of Southern California, Los Angeles, CA 90033, United States., Liu SV; Georgetown Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20007, United States., Halmos B; Montefiore Einstein Comprehensive Cancer Center, Bronx, NY 10461, United States., Hoon DSB; Saint John's Cancer Institute, Providence Health System, Santa Monica, CA 90404, United States., Seeber A; Tyrolean Cancer Research Institute, Innsbruck Medical University, Innsbruck 6020, Austria., Ma PC; Division of Hematology/Oncology, Penn State Cancer Institute, Hershey, PA 17033, United States., El-Deiry WS; Legorreta Cancer Center, Warren Alpert Medical School of Brown University, Providence, RI 02912, United States., Vanderwalde AM; Caris Life Sciences, Phoenix, AZ 85040, United States., Lopes G; Department of Medicine, Division of Medical Oncology, University of Miami Sylvester Comprehensive Cancer Center/Jackson Memorial Hospital, Miami, FL 33131, United States.

المصدر: The oncologist [Oncologist] 2024 Jul 10. Date of Electronic Publication: 2024 Jul 10.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 9607837 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-490X (Electronic) Linking ISSN: 10837159 NLM ISO Abbreviation: Oncologist Subsets: MEDLINE

المؤلفون: In GK; Division of Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. Gino.In@med.usc.edu., Ribeiro JR; Caris Life Sciences, Phoenix, AZ, USA., Yin J; Caris Life Sciences, Phoenix, AZ, USA., Xiu J; Caris Life Sciences, Phoenix, AZ, USA., Bustos MA; Department of Translational Molecular Medicine, Saint John's Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, USA., Ito F; Department of Surgery, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Chow F; Department of Neurology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.; Department of Neurological Surgery, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Zada G; Department of Neurological Surgery, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Hwang L; LAC+USC Medical Center, Los Angeles, CA, USA.; Department of Radiation Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Salama AKS; Division of Medical Oncology, Duke Cancer Institute, Duke University, Durham, NC, USA., Park SJ; Division of Hematology/Oncology, Moores Cancer Center, University of California San Diego, La Jolla, CA, USA., Moser JC; HonorHealth Research and Innovation Institute, Scottsdale, AZ, USA., Darabi S; Hoag Family Cancer Institute, Hoag Hospital, Newport Beach, CA, USA., Domingo-Musibay E; Department of Medicine, Masonic Cancer Center, University of Minnesota Medical School, Minneapolis, MN, USA., Ascierto ML; Rosalie and Harold Rae Brown Cancer Immunotherapy Research Program, Borstein Family Melanoma Program, Department of Translational Immunology, Saint John's Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, USA., Margolin K; Department of Medical Oncology, Saint John's Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, USA., Lutzky J; Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL, USA., Gibney GT; Division of Hematology and Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Hospital, Washington, DC, USA., Atkins MB; Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC, USA., Izar B; Columbia University, Herbert Irving Comprehensive Cancer Center, New York, NY, USA., Hoon DSB; Department of Translational Molecular Medicine, Saint John's Cancer Institute, Providence Saint John's Health Center, Santa Monica, CA, USA., VanderWalde AM; Caris Life Sciences, Irving, TX, USA.; West Cancer Center and Research Institute, 514 Chickasawba St., Blytheville, Arkansas, 72315, USA.

المصدر: NPJ precision oncology [NPJ Precis Oncol] 2023 Nov 14; Vol. 7 (1), pp. 120. Date of Electronic Publication: 2023 Nov 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE

المؤلفون: Hsu R; Department of Internal Medicine, Division of Medical Oncology, University of Southern California, Los Angeles, CA, United States.; Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, United States., Chen D; Department of Internal Medicine, Division of Medical Oncology, University of Southern California, Los Angeles, CA, United States.; Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, United States., Xia B; Department of Internal Medicine, Division of Medical Oncology, University of Southern California, Los Angeles, CA, United States.; Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, United States., Feldman R; Caris Life Sciences, Phoenix, AZ, United States., Cozen W; Division of Hematology-Oncology, Department of Medicine, University of California Irvine School of Medicine, Chao Family Comprehensive Cancer Center, Orange, CA, United States., Raez LE; Thoracic Oncology Program, Memorial Cancer Institute/Florida Atlantic University, Pembroke Pines, FL, United States., Borghaei H; Department of Hematology-Oncology, Fox Chase Cancer Center, Philadelphia, PA, United States., Kim C; Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, DC, United States., Nagasaka M; Division of Hematology-Oncology, Department of Medicine, University of California Irvine School of Medicine, Chao Family Comprehensive Cancer Center, Orange, CA, United States., Mamdani H; Department of Oncology, Barbara Ann Karmanos Cancer Institute, Detroit, MI, United States., Vanderwalde AM; Caris Life Sciences, Phoenix, AZ, United States., Lopes G; Department of Medical Oncology, Sylvester Comprehensive Cancer Center at the University of Miami, Miami, FL, United States., Socinski MA; AdventHealth Cancer Institute, Orlando, FL, United States., Wozniak AJ; Hillman Cancer Center, Department of Medicine, Division of Hematology/Oncology, University of Pittsburgh Medical Center, Pittsburgh, PA, United States., Spira AI; US Oncology Research, Virginia Cancer Specialists, Fairfax, VA, United States., Liu SV; Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, DC, United States., Nieva JJ; Department of Internal Medicine, Division of Medical Oncology, University of Southern California, Los Angeles, CA, United States.; Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, United States.

المصدر: Frontiers in oncology [Front Oncol] 2023 Aug 28; Vol. 13, pp. 1215524. Date of Electronic Publication: 2023 Aug 28 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

المؤلفون: Guo M; Department of Internal Medicine, AdventHealth Orlando, Orlando, FL., VanderWalde AM; Medical Oncology, West Cancer Center & Research Institute, Germantown, TN; Department of Clinical Development, Caris Life Sciences, Irving, TX., Yu X; Division of Epidemiology, Biostatistics, and Environmental Health, School of Public Health, University of Memphis, Memphis, TN., Vidal GA; Medical Oncology, West Cancer Center & Research Institute, Germantown, TN; Department of Hematology/Oncology, University of Tennessee Health Science Center, Memphis, TN., Tian GG; Medical Oncology, West Cancer Center & Research Institute, Germantown, TN. Electronic address: gtian@westclinic.com.

المصدر: Clinical lung cancer [Clin Lung Cancer] 2022 Dec; Vol. 23 (8), pp. 686-693. Date of Electronic Publication: 2022 Aug 08.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 100893225 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0690 (Electronic) Linking ISSN: 15257304 NLM ISO Abbreviation: Clin Lung Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung*/pathology , Antineoplastic Agents, Immunological*/adverse effects , Lung Neoplasms*/pathology , Drug-Related Side Effects and Adverse Reactions*/etiology, Adult ; Humans ; Immune Checkpoint Inhibitors/adverse effects ; Retrospective Studies

المؤلفون: Cerniglia M; St Joseph Hospital, Denver, Colorado., Xiu J; Caris Life Sciences, Phoenix, Arizona., Grothey A; West Cancer Center, Germantown, Tennessee., Pishvaian MJ; NCR Kimmel Cancer Center, Sibley Memorial Hospital and Johns Hopkins University School of Medicine, Washington, District of Columbia., Baca Y; Caris Life Sciences, Phoenix, Arizona., Hwang JJ; Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina., Marshall JL; Ruesch Center for The Cure of Gastrointestinal Cancers, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia., VanderWalde AM; West Cancer Center, Germantown, Tennessee., Shields AF; Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan., Lenz HJ; Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of, Medicine, University of Southern California, Los Angeles, California., Korn WM; Caris Life Sciences, Phoenix, Arizona., Salem M; Levine Cancer Institute, Carolinas HealthCare System, Charlotte, North Carolina., Philip PA; Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan., Goldberg RM; West Virginia University Cancer Institute, Morgantown, West Virginia., Zeng J; Caris Life Sciences, Phoenix, Arizona., Kim SS; Division of Medical Oncology, University of Colorado Cancer Center, Aurora, Colorado. sunnie.kim@cuanschutz.edu.

المصدر: Molecular cancer therapeutics [Mol Cancer Ther] 2022 Jan; Vol. 21 (1), pp. 227-236. Date of Electronic Publication: 2021 Nov 01.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE

مواضيع طبية MeSH: Biomarkers, Tumor/*metabolism , DNA Damage/*genetics , Esophageal Neoplasms/*genetics , High-Throughput Nucleotide Sequencing/*methods , Homologous Recombination/*genetics , Stomach Neoplasms/*genetics, Aged ; Esophageal Neoplasms/pathology ; Female ; Humans ; Male ; Middle Aged ; Mutation ; Stomach Neoplasms/pathology

المؤلفون: Judd J; Department of Hematology-Oncology, Fox Chase Cancer Center, Temple University Health System, Philadelphia, Pennsylvania., Abdel Karim N; Department of Hematology-Oncology, Augusta University-Medical College of Georgia, Georgia Cancer Center, Augusta, Georgia., Khan H; Department of Hematology-Oncology, The Warren Alpert Medical School, Brown University, Providence, Rhode Isand., Naqash AR; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.; Medical Oncology/TSET Phase 1 Program, Stephenson Cancer Center, University of Oklahoma, Oklahoma City, Oklahoma., Baca Y; Caris Life Sciences, Phoenix, Arizona., Xiu J; Caris Life Sciences, Phoenix, Arizona., VanderWalde AM; Department of Medical Oncology, West Cancer Center and Research Institute, Memphis, Tennessee., Mamdani H; Department of Oncology, Karmanos Cancer Institute/Wayne State University, Detroit, Michigan., Raez LE; Department of Hematology-Oncology, Memorial Cancer Institute/Memorial Health Care System/Florida International University, Hollywood, Florida., Nagasaka M; Department of Oncology, Karmanos Cancer Institute/Wayne State University, Detroit, Michigan., Pai SG; Department of Medical Oncology, Mitchell Cancer Institute, University of South Alabama, Mobile, Alabama., Socinski MA; Department of Medical Oncology, AdventHealth Cancer Institute, Orlando, Florida., Nieva JJ; Department of Medical Oncology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California., Kim C; Department of Hematology-Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC., Wozniak AJ; Department of Medical Oncology, University of Pittsburgh Medical Center, Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania., Ikpeazu C; Department of Medical Oncology, Sylvester Comprehensive Cancer Center, University of Miami and the Miller School of Medicine, Miami, Florida., de Lima Lopes G Jr; Department of Medical Oncology, Sylvester Comprehensive Cancer Center, University of Miami and the Miller School of Medicine, Miami, Florida., Spira AI; Department of Medical Oncology, Virginia Cancer Specialists, US Oncology Research, Fairfax, Virginia., Korn WM; Caris Life Sciences, Phoenix, Arizona., Kim ES; Department of Medical Oncology, City of Hope, Los Angeles, California., Liu SV; Department of Hematology-Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC., Borghaei H; Department of Hematology-Oncology, Fox Chase Cancer Center, Temple University Health System, Philadelphia, Pennsylvania. hossein.borghaei@fccc.edu.

المصدر: Molecular cancer therapeutics [Mol Cancer Ther] 2021 Dec; Vol. 20 (12), pp. 2577-2584. Date of Electronic Publication: 2021 Sep 13.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Non-Small-Cell Lung/*drug therapy , High-Throughput Nucleotide Sequencing/*methods , Lung Neoplasms/*drug therapy , Proto-Oncogene Proteins p21(ras)/*metabolism, Carcinoma, Non-Small-Cell Lung/genetics ; Humans ; Microsatellite Instability ; Mutation ; Prognosis ; Proto-Oncogene Proteins p21(ras)/genetics

المؤلفون: Loree JM; BC Cancer, Vancouver, British Columbia, Canada., Wang Y; Mayo Clinic, Rochester, Minnesota., Syed MA; The University of Texas MD Anderson Cancer Center, Houston, Texas., Sorokin AV; The University of Texas MD Anderson Cancer Center, Houston, Texas., Coker O; The University of Texas MD Anderson Cancer Center, Houston, Texas., Xiu J; Caris Life Sciences, Phoenix, Arizona., Weinberg BA; Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC., Vanderwalde AM; West Cancer Center, Memphis, Tennessee., Tesfaye A; Karmanos Cancer Institute, Rochester Hills, Michigan., Raymond VM; Guardant Health Inc., Redwood City, California., Miron B; Novellus, Jerusalem, Israel., Tarcic G; Novellus, Jerusalem, Israel., Zelichov O; Novellus, Jerusalem, Israel., Broaddus RR; University of North Carolina, Chapel Hill, North Carolina., Ng PKS; The University of Texas MD Anderson Cancer Center, Houston, Texas., Jeong KJ; Oregon Health Sciences University Knight Cancer Institute, Portland, Oregon., Tsang YH; Oregon Health Sciences University Knight Cancer Institute, Portland, Oregon., Mills GB; Oregon Health Sciences University Knight Cancer Institute, Portland, Oregon., Overman MJ; The University of Texas MD Anderson Cancer Center, Houston, Texas., Grothey A; West Cancer Center, Memphis, Tennessee., Marshall JL; Caris Life Sciences, Phoenix, Arizona., Kopetz S; The University of Texas MD Anderson Cancer Center, Houston, Texas. skopetz@mdanderson.org.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Aug 15; Vol. 27 (16), pp. 4587-4598. Date of Electronic Publication: 2021 Jun 11.

نوع المنشور: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Mutation*, Colorectal Neoplasms/*genetics , GTP Phosphohydrolases/*genetics , Membrane Proteins/*genetics , Proto-Oncogene Proteins p21(ras)/*genetics, Aged ; Colorectal Neoplasms/pathology ; Female ; Humans ; Male ; Middle Aged ; Neoplasm Metastasis

المؤلفون: Borden BA; The Warren Alpert Medical School of Brown University, Providence, Rhode Island., Baca Y; Caris Life Sciences, Phoenix, Arizona., Xiu J; Caris Life Sciences, Phoenix, Arizona., Tavora F; The Warren Alpert Medical School of Brown University, Providence, Rhode Island.; Division of Hematology/Oncology, Lifespan Cancer Institute, Providence, Rhode Island., Winer I; Wayne State School of Medicine, Karmanos Cancer Institute, Detroit, Michigan., Weinberg BA; Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC., Vanderwalde AM; West Cancer Center, Memphis, Tennessee., Darabi S; Hoag Family Cancer Institute, Newport Beach, California., Korn WM; Caris Life Sciences, Phoenix, Arizona., Mazar AP; Monopar Therapeutics, Wilmette, Illinois., Giles FJ; Developmental Therapeutics Consortium, Chicago, Illinois., Crawford L; Department of Biostatistics, Brown University, Providence, Rhode Island., Safran H; The Warren Alpert Medical School of Brown University, Providence, Rhode Island.; Division of Hematology/Oncology, Lifespan Cancer Institute, Providence, Rhode Island.; Joint Program in Cancer Biology, Brown University and Lifespan Health System, Providence, Rhode Island., El-Deiry WS; The Warren Alpert Medical School of Brown University, Providence, Rhode Island.; Division of Hematology/Oncology, Lifespan Cancer Institute, Providence, Rhode Island.; Joint Program in Cancer Biology, Brown University and Lifespan Health System, Providence, Rhode Island.; Department of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island., Carneiro BA; The Warren Alpert Medical School of Brown University, Providence, Rhode Island. benedito_carneiro@brown.edu.; Division of Hematology/Oncology, Lifespan Cancer Institute, Providence, Rhode Island.; Joint Program in Cancer Biology, Brown University and Lifespan Health System, Providence, Rhode Island.

المصدر: Molecular cancer therapeutics [Mol Cancer Ther] 2021 Jan; Vol. 20 (1), pp. 183-190. Date of Electronic Publication: 2020 Oct 21.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE

مواضيع طبية MeSH: Genome, Human*, Glycogen Synthase Kinase 3 beta/*metabolism , Neoplasms/*enzymology , Neoplasms/*genetics, B7-H1 Antigen/metabolism ; Cohort Studies ; DNA Copy Number Variations/genetics ; Glycogen Synthase Kinase 3 beta/genetics ; Humans ; Mutation/genetics ; RNA, Messenger/genetics ; RNA, Messenger/metabolism ; Tumor Microenvironment/genetics